(Total Views: 489)
Posted On: 02/05/2021 11:19:48 AM
Post# of 155002
I could be wrong jeff67, but the J&J vaccine was just 65% or so effective if I remember correctly and correct me if I'm wrong. That could be the reason that the fda is not as anxious to review quickly compared to the 94+_% that Phizer and Maderna had. They were more in line with what the fda was looking for.
Now, if CYDY's Vyrologix has a great % reduction in the 28 day all cause mortality, and it's the best of all mab's, the fda will react quickly in reviewing and please, this is my own opinion only but it could come out that way.
The fda said, "don't complete the entire top line results of your CD-12 phase 3 trial, immediately after unblinding, send us those results of all cause mortality, am I right?
GLTU
HCIT
Now, if CYDY's Vyrologix has a great % reduction in the 28 day all cause mortality, and it's the best of all mab's, the fda will react quickly in reviewing and please, this is my own opinion only but it could come out that way.
The fda said, "don't complete the entire top line results of your CD-12 phase 3 trial, immediately after unblinding, send us those results of all cause mortality, am I right?
GLTU
HCIT
(4)
(0)
